Global Cell-Based Immunotherapy Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Cell-Based Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-Based Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-Based Immunotherapy market in any manner.
Global Cell-Based Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
Market Segmentation (by Type)
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
Market Segmentation (by Application)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-Based Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Cell-Based Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-Based Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-Based Immunotherapy market in any manner.
Global Cell-Based Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
Market Segmentation (by Type)
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
Market Segmentation (by Application)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell-Based Immunotherapy Market
- Overview of the regional outlook of the Cell-Based Immunotherapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-Based Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell-Based Immunotherapy
1.2 Key Market Segments
1.2.1 Cell-Based Immunotherapy Segment by Type
1.2.2 Cell-Based Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-BASED IMMUNOTHERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-Based Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-Based Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-BASED IMMUNOTHERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-Based Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Cell-Based Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-Based Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-Based Immunotherapy Sales Sites, Area Served, Product Type
3.6 Cell-Based Immunotherapy Market Competitive Situation and Trends
3.6.1 Cell-Based Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-Based Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-BASED IMMUNOTHERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cell-Based Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-BASED IMMUNOTHERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-Based Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Cell-Based Immunotherapy Price by Type (2019-2024)
7 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-Based Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Cell-Based Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
8 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY REGION
8.1 Global Cell-Based Immunotherapy Sales by Region
8.1.1 Global Cell-Based Immunotherapy Sales by Region
8.1.2 Global Cell-Based Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-Based Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-Based Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-Based Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-Based Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-Based Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis Cell-Based Immunotherapy Basic Information
9.1.2 Novartis Cell-Based Immunotherapy Product Overview
9.1.3 Novartis Cell-Based Immunotherapy Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Cell-Based Immunotherapy SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences Cell-Based Immunotherapy Basic Information
9.2.2 Gilead Sciences Cell-Based Immunotherapy Product Overview
9.2.3 Gilead Sciences Cell-Based Immunotherapy Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences Cell-Based Immunotherapy SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 AbbVie
9.3.1 AbbVie Cell-Based Immunotherapy Basic Information
9.3.2 AbbVie Cell-Based Immunotherapy Product Overview
9.3.3 AbbVie Cell-Based Immunotherapy Product Market Performance
9.3.4 AbbVie Cell-Based Immunotherapy SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Cell-Based Immunotherapy Basic Information
9.4.2 Bristol-Myers Squibb Cell-Based Immunotherapy Product Overview
9.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Amgen
9.5.1 Amgen Cell-Based Immunotherapy Basic Information
9.5.2 Amgen Cell-Based Immunotherapy Product Overview
9.5.3 Amgen Cell-Based Immunotherapy Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Cell-Based Immunotherapy Basic Information
9.6.2 AstraZeneca Cell-Based Immunotherapy Product Overview
9.6.3 AstraZeneca Cell-Based Immunotherapy Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Biogen
9.7.1 Biogen Cell-Based Immunotherapy Basic Information
9.7.2 Biogen Cell-Based Immunotherapy Product Overview
9.7.3 Biogen Cell-Based Immunotherapy Product Market Performance
9.7.4 Biogen Business Overview
9.7.5 Biogen Recent Developments
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Cell-Based Immunotherapy Basic Information
9.8.2 Boehringer Ingelheim Cell-Based Immunotherapy Product Overview
9.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Product Market Performance
9.8.4 Boehringer Ingelheim Business Overview
9.8.5 Boehringer Ingelheim Recent Developments
9.9 Eli Lilly and Company
9.9.1 Eli Lilly and Company Cell-Based Immunotherapy Basic Information
9.9.2 Eli Lilly and Company Cell-Based Immunotherapy Product Overview
9.9.3 Eli Lilly and Company Cell-Based Immunotherapy Product Market Performance
9.9.4 Eli Lilly and Company Business Overview
9.9.5 Eli Lilly and Company Recent Developments
9.10 GSK
9.10.1 GSK Cell-Based Immunotherapy Basic Information
9.10.2 GSK Cell-Based Immunotherapy Product Overview
9.10.3 GSK Cell-Based Immunotherapy Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Pfizer
9.11.1 Pfizer Cell-Based Immunotherapy Basic Information
9.11.2 Pfizer Cell-Based Immunotherapy Product Overview
9.11.3 Pfizer Cell-Based Immunotherapy Product Market Performance
9.11.4 Pfizer Business Overview
9.11.5 Pfizer Recent Developments
9.12 Roche
9.12.1 Roche Cell-Based Immunotherapy Basic Information
9.12.2 Roche Cell-Based Immunotherapy Product Overview
9.12.3 Roche Cell-Based Immunotherapy Product Market Performance
9.12.4 Roche Business Overview
9.12.5 Roche Recent Developments
9.13 Takara Bio
9.13.1 Takara Bio Cell-Based Immunotherapy Basic Information
9.13.2 Takara Bio Cell-Based Immunotherapy Product Overview
9.13.3 Takara Bio Cell-Based Immunotherapy Product Market Performance
9.13.4 Takara Bio Business Overview
9.13.5 Takara Bio Recent Developments
9.14 Bausch Health
9.14.1 Bausch Health Cell-Based Immunotherapy Basic Information
9.14.2 Bausch Health Cell-Based Immunotherapy Product Overview
9.14.3 Bausch Health Cell-Based Immunotherapy Product Market Performance
9.14.4 Bausch Health Business Overview
9.14.5 Bausch Health Recent Developments
9.15 Apac Biotech
9.15.1 Apac Biotech Cell-Based Immunotherapy Basic Information
9.15.2 Apac Biotech Cell-Based Immunotherapy Product Overview
9.15.3 Apac Biotech Cell-Based Immunotherapy Product Market Performance
9.15.4 Apac Biotech Business Overview
9.15.5 Apac Biotech Recent Developments
9.16 Dendreon Pharmaceuticals (SanPower)
9.16.1 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Basic Information
9.16.2 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Overview
9.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Market Performance
9.16.4 Dendreon Pharmaceuticals (SanPower) Business Overview
9.16.5 Dendreon Pharmaceuticals (SanPower) Recent Developments
9.17 JW CreaGene
9.17.1 JW CreaGene Cell-Based Immunotherapy Basic Information
9.17.2 JW CreaGene Cell-Based Immunotherapy Product Overview
9.17.3 JW CreaGene Cell-Based Immunotherapy Product Market Performance
9.17.4 JW CreaGene Business Overview
9.17.5 JW CreaGene Recent Developments
9.18 Green Cross Corp
9.18.1 Green Cross Corp Cell-Based Immunotherapy Basic Information
9.18.2 Green Cross Corp Cell-Based Immunotherapy Product Overview
9.18.3 Green Cross Corp Cell-Based Immunotherapy Product Market Performance
9.18.4 Green Cross Corp Business Overview
9.18.5 Green Cross Corp Recent Developments
10 CELL-BASED IMMUNOTHERAPY MARKET FORECAST BY REGION
10.1 Global Cell-Based Immunotherapy Market Size Forecast
10.2 Global Cell-Based Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-Based Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Cell-Based Immunotherapy Market Size Forecast by Region
10.2.4 South America Cell-Based Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-Based Immunotherapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-Based Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-Based Immunotherapy by Type (2025-2030)
11.1.2 Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-Based Immunotherapy by Type (2025-2030)
11.2 Global Cell-Based Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Cell-Based Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Cell-Based Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell-Based Immunotherapy
1.2 Key Market Segments
1.2.1 Cell-Based Immunotherapy Segment by Type
1.2.2 Cell-Based Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-BASED IMMUNOTHERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-Based Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-Based Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-BASED IMMUNOTHERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-Based Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Cell-Based Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-Based Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-Based Immunotherapy Sales Sites, Area Served, Product Type
3.6 Cell-Based Immunotherapy Market Competitive Situation and Trends
3.6.1 Cell-Based Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-Based Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-BASED IMMUNOTHERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cell-Based Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-BASED IMMUNOTHERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-Based Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Cell-Based Immunotherapy Price by Type (2019-2024)
7 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-Based Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Cell-Based Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
8 CELL-BASED IMMUNOTHERAPY MARKET SEGMENTATION BY REGION
8.1 Global Cell-Based Immunotherapy Sales by Region
8.1.1 Global Cell-Based Immunotherapy Sales by Region
8.1.2 Global Cell-Based Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-Based Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-Based Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-Based Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-Based Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-Based Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis Cell-Based Immunotherapy Basic Information
9.1.2 Novartis Cell-Based Immunotherapy Product Overview
9.1.3 Novartis Cell-Based Immunotherapy Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Cell-Based Immunotherapy SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences Cell-Based Immunotherapy Basic Information
9.2.2 Gilead Sciences Cell-Based Immunotherapy Product Overview
9.2.3 Gilead Sciences Cell-Based Immunotherapy Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences Cell-Based Immunotherapy SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 AbbVie
9.3.1 AbbVie Cell-Based Immunotherapy Basic Information
9.3.2 AbbVie Cell-Based Immunotherapy Product Overview
9.3.3 AbbVie Cell-Based Immunotherapy Product Market Performance
9.3.4 AbbVie Cell-Based Immunotherapy SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Cell-Based Immunotherapy Basic Information
9.4.2 Bristol-Myers Squibb Cell-Based Immunotherapy Product Overview
9.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Amgen
9.5.1 Amgen Cell-Based Immunotherapy Basic Information
9.5.2 Amgen Cell-Based Immunotherapy Product Overview
9.5.3 Amgen Cell-Based Immunotherapy Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Cell-Based Immunotherapy Basic Information
9.6.2 AstraZeneca Cell-Based Immunotherapy Product Overview
9.6.3 AstraZeneca Cell-Based Immunotherapy Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Biogen
9.7.1 Biogen Cell-Based Immunotherapy Basic Information
9.7.2 Biogen Cell-Based Immunotherapy Product Overview
9.7.3 Biogen Cell-Based Immunotherapy Product Market Performance
9.7.4 Biogen Business Overview
9.7.5 Biogen Recent Developments
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Cell-Based Immunotherapy Basic Information
9.8.2 Boehringer Ingelheim Cell-Based Immunotherapy Product Overview
9.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Product Market Performance
9.8.4 Boehringer Ingelheim Business Overview
9.8.5 Boehringer Ingelheim Recent Developments
9.9 Eli Lilly and Company
9.9.1 Eli Lilly and Company Cell-Based Immunotherapy Basic Information
9.9.2 Eli Lilly and Company Cell-Based Immunotherapy Product Overview
9.9.3 Eli Lilly and Company Cell-Based Immunotherapy Product Market Performance
9.9.4 Eli Lilly and Company Business Overview
9.9.5 Eli Lilly and Company Recent Developments
9.10 GSK
9.10.1 GSK Cell-Based Immunotherapy Basic Information
9.10.2 GSK Cell-Based Immunotherapy Product Overview
9.10.3 GSK Cell-Based Immunotherapy Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Pfizer
9.11.1 Pfizer Cell-Based Immunotherapy Basic Information
9.11.2 Pfizer Cell-Based Immunotherapy Product Overview
9.11.3 Pfizer Cell-Based Immunotherapy Product Market Performance
9.11.4 Pfizer Business Overview
9.11.5 Pfizer Recent Developments
9.12 Roche
9.12.1 Roche Cell-Based Immunotherapy Basic Information
9.12.2 Roche Cell-Based Immunotherapy Product Overview
9.12.3 Roche Cell-Based Immunotherapy Product Market Performance
9.12.4 Roche Business Overview
9.12.5 Roche Recent Developments
9.13 Takara Bio
9.13.1 Takara Bio Cell-Based Immunotherapy Basic Information
9.13.2 Takara Bio Cell-Based Immunotherapy Product Overview
9.13.3 Takara Bio Cell-Based Immunotherapy Product Market Performance
9.13.4 Takara Bio Business Overview
9.13.5 Takara Bio Recent Developments
9.14 Bausch Health
9.14.1 Bausch Health Cell-Based Immunotherapy Basic Information
9.14.2 Bausch Health Cell-Based Immunotherapy Product Overview
9.14.3 Bausch Health Cell-Based Immunotherapy Product Market Performance
9.14.4 Bausch Health Business Overview
9.14.5 Bausch Health Recent Developments
9.15 Apac Biotech
9.15.1 Apac Biotech Cell-Based Immunotherapy Basic Information
9.15.2 Apac Biotech Cell-Based Immunotherapy Product Overview
9.15.3 Apac Biotech Cell-Based Immunotherapy Product Market Performance
9.15.4 Apac Biotech Business Overview
9.15.5 Apac Biotech Recent Developments
9.16 Dendreon Pharmaceuticals (SanPower)
9.16.1 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Basic Information
9.16.2 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Overview
9.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Market Performance
9.16.4 Dendreon Pharmaceuticals (SanPower) Business Overview
9.16.5 Dendreon Pharmaceuticals (SanPower) Recent Developments
9.17 JW CreaGene
9.17.1 JW CreaGene Cell-Based Immunotherapy Basic Information
9.17.2 JW CreaGene Cell-Based Immunotherapy Product Overview
9.17.3 JW CreaGene Cell-Based Immunotherapy Product Market Performance
9.17.4 JW CreaGene Business Overview
9.17.5 JW CreaGene Recent Developments
9.18 Green Cross Corp
9.18.1 Green Cross Corp Cell-Based Immunotherapy Basic Information
9.18.2 Green Cross Corp Cell-Based Immunotherapy Product Overview
9.18.3 Green Cross Corp Cell-Based Immunotherapy Product Market Performance
9.18.4 Green Cross Corp Business Overview
9.18.5 Green Cross Corp Recent Developments
10 CELL-BASED IMMUNOTHERAPY MARKET FORECAST BY REGION
10.1 Global Cell-Based Immunotherapy Market Size Forecast
10.2 Global Cell-Based Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-Based Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Cell-Based Immunotherapy Market Size Forecast by Region
10.2.4 South America Cell-Based Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-Based Immunotherapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-Based Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-Based Immunotherapy by Type (2025-2030)
11.1.2 Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-Based Immunotherapy by Type (2025-2030)
11.2 Global Cell-Based Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Cell-Based Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Cell-Based Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-Based Immunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Cell-Based Immunotherapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-Based Immunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-Based Immunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-Based Immunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2022)
Table 10. Global Market Cell-Based Immunotherapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-Based Immunotherapy Sales Sites and Area Served
Table 12. Manufacturers Cell-Based Immunotherapy Product Type
Table 13. Global Cell-Based Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-Based Immunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-Based Immunotherapy Market Challenges
Table 22. Global Cell-Based Immunotherapy Sales by Type (K Units)
Table 23. Global Cell-Based Immunotherapy Market Size by Type (M USD)
Table 24. Global Cell-Based Immunotherapy Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-Based Immunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Cell-Based Immunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-Based Immunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Cell-Based Immunotherapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-Based Immunotherapy Sales (K Units) by Application
Table 30. Global Cell-Based Immunotherapy Market Size by Application
Table 31. Global Cell-Based Immunotherapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-Based Immunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Cell-Based Immunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-Based Immunotherapy Market Share by Application (2019-2024)
Table 35. Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-Based Immunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 43. Novartis Cell-Based Immunotherapy Basic Information
Table 44. Novartis Cell-Based Immunotherapy Product Overview
Table 45. Novartis Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Cell-Based Immunotherapy SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Cell-Based Immunotherapy Basic Information
Table 50. Gilead Sciences Cell-Based Immunotherapy Product Overview
Table 51. Gilead Sciences Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Cell-Based Immunotherapy SWOT Analysis
Table 54. Gilead Sciences Recent Developments
Table 55. AbbVie Cell-Based Immunotherapy Basic Information
Table 56. AbbVie Cell-Based Immunotherapy Product Overview
Table 57. AbbVie Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AbbVie Cell-Based Immunotherapy SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. Bristol-Myers Squibb Cell-Based Immunotherapy Basic Information
Table 62. Bristol-Myers Squibb Cell-Based Immunotherapy Product Overview
Table 63. Bristol-Myers Squibb Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Amgen Cell-Based Immunotherapy Basic Information
Table 67. Amgen Cell-Based Immunotherapy Product Overview
Table 68. Amgen Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. AstraZeneca Cell-Based Immunotherapy Basic Information
Table 72. AstraZeneca Cell-Based Immunotherapy Product Overview
Table 73. AstraZeneca Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Biogen Cell-Based Immunotherapy Basic Information
Table 77. Biogen Cell-Based Immunotherapy Product Overview
Table 78. Biogen Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Biogen Business Overview
Table 80. Biogen Recent Developments
Table 81. Boehringer Ingelheim Cell-Based Immunotherapy Basic Information
Table 82. Boehringer Ingelheim Cell-Based Immunotherapy Product Overview
Table 83. Boehringer Ingelheim Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Eli Lilly and Company Cell-Based Immunotherapy Basic Information
Table 87. Eli Lilly and Company Cell-Based Immunotherapy Product Overview
Table 88. Eli Lilly and Company Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Recent Developments
Table 91. GSK Cell-Based Immunotherapy Basic Information
Table 92. GSK Cell-Based Immunotherapy Product Overview
Table 93. GSK Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. GSK Business Overview
Table 95. GSK Recent Developments
Table 96. Pfizer Cell-Based Immunotherapy Basic Information
Table 97. Pfizer Cell-Based Immunotherapy Product Overview
Table 98. Pfizer Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer Business Overview
Table 100. Pfizer Recent Developments
Table 101. Roche Cell-Based Immunotherapy Basic Information
Table 102. Roche Cell-Based Immunotherapy Product Overview
Table 103. Roche Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Roche Business Overview
Table 105. Roche Recent Developments
Table 106. Takara Bio Cell-Based Immunotherapy Basic Information
Table 107. Takara Bio Cell-Based Immunotherapy Product Overview
Table 108. Takara Bio Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takara Bio Business Overview
Table 110. Takara Bio Recent Developments
Table 111. Bausch Health Cell-Based Immunotherapy Basic Information
Table 112. Bausch Health Cell-Based Immunotherapy Product Overview
Table 113. Bausch Health Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bausch Health Business Overview
Table 115. Bausch Health Recent Developments
Table 116. Apac Biotech Cell-Based Immunotherapy Basic Information
Table 117. Apac Biotech Cell-Based Immunotherapy Product Overview
Table 118. Apac Biotech Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Apac Biotech Business Overview
Table 120. Apac Biotech Recent Developments
Table 121. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Basic Information
Table 122. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Overview
Table 123. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Dendreon Pharmaceuticals (SanPower) Business Overview
Table 125. Dendreon Pharmaceuticals (SanPower) Recent Developments
Table 126. JW CreaGene Cell-Based Immunotherapy Basic Information
Table 127. JW CreaGene Cell-Based Immunotherapy Product Overview
Table 128. JW CreaGene Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. JW CreaGene Business Overview
Table 130. JW CreaGene Recent Developments
Table 131. Green Cross Corp Cell-Based Immunotherapy Basic Information
Table 132. Green Cross Corp Cell-Based Immunotherapy Product Overview
Table 133. Green Cross Corp Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Green Cross Corp Business Overview
Table 135. Green Cross Corp Recent Developments
Table 136. Global Cell-Based Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Cell-Based Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Cell-Based Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Cell-Based Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Cell-Based Immunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Cell-Based Immunotherapy Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Cell-Based Immunotherapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Cell-Based Immunotherapy Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Cell-Based Immunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-Based Immunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Cell-Based Immunotherapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-Based Immunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-Based Immunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-Based Immunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2022)
Table 10. Global Market Cell-Based Immunotherapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-Based Immunotherapy Sales Sites and Area Served
Table 12. Manufacturers Cell-Based Immunotherapy Product Type
Table 13. Global Cell-Based Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-Based Immunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-Based Immunotherapy Market Challenges
Table 22. Global Cell-Based Immunotherapy Sales by Type (K Units)
Table 23. Global Cell-Based Immunotherapy Market Size by Type (M USD)
Table 24. Global Cell-Based Immunotherapy Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-Based Immunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Cell-Based Immunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-Based Immunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Cell-Based Immunotherapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-Based Immunotherapy Sales (K Units) by Application
Table 30. Global Cell-Based Immunotherapy Market Size by Application
Table 31. Global Cell-Based Immunotherapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-Based Immunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Cell-Based Immunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-Based Immunotherapy Market Share by Application (2019-2024)
Table 35. Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-Based Immunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-Based Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-Based Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 43. Novartis Cell-Based Immunotherapy Basic Information
Table 44. Novartis Cell-Based Immunotherapy Product Overview
Table 45. Novartis Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Cell-Based Immunotherapy SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Cell-Based Immunotherapy Basic Information
Table 50. Gilead Sciences Cell-Based Immunotherapy Product Overview
Table 51. Gilead Sciences Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Cell-Based Immunotherapy SWOT Analysis
Table 54. Gilead Sciences Recent Developments
Table 55. AbbVie Cell-Based Immunotherapy Basic Information
Table 56. AbbVie Cell-Based Immunotherapy Product Overview
Table 57. AbbVie Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AbbVie Cell-Based Immunotherapy SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. Bristol-Myers Squibb Cell-Based Immunotherapy Basic Information
Table 62. Bristol-Myers Squibb Cell-Based Immunotherapy Product Overview
Table 63. Bristol-Myers Squibb Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Amgen Cell-Based Immunotherapy Basic Information
Table 67. Amgen Cell-Based Immunotherapy Product Overview
Table 68. Amgen Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. AstraZeneca Cell-Based Immunotherapy Basic Information
Table 72. AstraZeneca Cell-Based Immunotherapy Product Overview
Table 73. AstraZeneca Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Biogen Cell-Based Immunotherapy Basic Information
Table 77. Biogen Cell-Based Immunotherapy Product Overview
Table 78. Biogen Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Biogen Business Overview
Table 80. Biogen Recent Developments
Table 81. Boehringer Ingelheim Cell-Based Immunotherapy Basic Information
Table 82. Boehringer Ingelheim Cell-Based Immunotherapy Product Overview
Table 83. Boehringer Ingelheim Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Eli Lilly and Company Cell-Based Immunotherapy Basic Information
Table 87. Eli Lilly and Company Cell-Based Immunotherapy Product Overview
Table 88. Eli Lilly and Company Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Recent Developments
Table 91. GSK Cell-Based Immunotherapy Basic Information
Table 92. GSK Cell-Based Immunotherapy Product Overview
Table 93. GSK Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. GSK Business Overview
Table 95. GSK Recent Developments
Table 96. Pfizer Cell-Based Immunotherapy Basic Information
Table 97. Pfizer Cell-Based Immunotherapy Product Overview
Table 98. Pfizer Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer Business Overview
Table 100. Pfizer Recent Developments
Table 101. Roche Cell-Based Immunotherapy Basic Information
Table 102. Roche Cell-Based Immunotherapy Product Overview
Table 103. Roche Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Roche Business Overview
Table 105. Roche Recent Developments
Table 106. Takara Bio Cell-Based Immunotherapy Basic Information
Table 107. Takara Bio Cell-Based Immunotherapy Product Overview
Table 108. Takara Bio Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takara Bio Business Overview
Table 110. Takara Bio Recent Developments
Table 111. Bausch Health Cell-Based Immunotherapy Basic Information
Table 112. Bausch Health Cell-Based Immunotherapy Product Overview
Table 113. Bausch Health Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bausch Health Business Overview
Table 115. Bausch Health Recent Developments
Table 116. Apac Biotech Cell-Based Immunotherapy Basic Information
Table 117. Apac Biotech Cell-Based Immunotherapy Product Overview
Table 118. Apac Biotech Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Apac Biotech Business Overview
Table 120. Apac Biotech Recent Developments
Table 121. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Basic Information
Table 122. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Overview
Table 123. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Dendreon Pharmaceuticals (SanPower) Business Overview
Table 125. Dendreon Pharmaceuticals (SanPower) Recent Developments
Table 126. JW CreaGene Cell-Based Immunotherapy Basic Information
Table 127. JW CreaGene Cell-Based Immunotherapy Product Overview
Table 128. JW CreaGene Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. JW CreaGene Business Overview
Table 130. JW CreaGene Recent Developments
Table 131. Green Cross Corp Cell-Based Immunotherapy Basic Information
Table 132. Green Cross Corp Cell-Based Immunotherapy Product Overview
Table 133. Green Cross Corp Cell-Based Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Green Cross Corp Business Overview
Table 135. Green Cross Corp Recent Developments
Table 136. Global Cell-Based Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Cell-Based Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Cell-Based Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Cell-Based Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Cell-Based Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Cell-Based Immunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Cell-Based Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Cell-Based Immunotherapy Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Cell-Based Immunotherapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Cell-Based Immunotherapy Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Cell-Based Immunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell-Based Immunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-Based Immunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Cell-Based Immunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Cell-Based Immunotherapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-Based Immunotherapy Market Size by Country (M USD)
Figure 11. Cell-Based Immunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Cell-Based Immunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-Based Immunotherapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-Based Immunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-Based Immunotherapy Market Share by Type
Figure 18. Sales Market Share of Cell-Based Immunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Cell-Based Immunotherapy by Type in 2023
Figure 20. Market Size Share of Cell-Based Immunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-Based Immunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-Based Immunotherapy Market Share by Application
Figure 24. Global Cell-Based Immunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-Based Immunotherapy Sales Market Share by Application in 2023
Figure 26. Global Cell-Based Immunotherapy Market Share by Application (2019-2024)
Figure 27. Global Cell-Based Immunotherapy Market Share by Application in 2023
Figure 28. Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-Based Immunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-Based Immunotherapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-Based Immunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-Based Immunotherapy Sales Market Share by Region in 2023
Figure 44. China Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 50. South America Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-Based Immunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-Based Immunotherapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-Based Immunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-Based Immunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-Based Immunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-Based Immunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-Based Immunotherapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cell-Based Immunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-Based Immunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Cell-Based Immunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Cell-Based Immunotherapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-Based Immunotherapy Market Size by Country (M USD)
Figure 11. Cell-Based Immunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Cell-Based Immunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-Based Immunotherapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-Based Immunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-Based Immunotherapy Market Share by Type
Figure 18. Sales Market Share of Cell-Based Immunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Cell-Based Immunotherapy by Type in 2023
Figure 20. Market Size Share of Cell-Based Immunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-Based Immunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-Based Immunotherapy Market Share by Application
Figure 24. Global Cell-Based Immunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-Based Immunotherapy Sales Market Share by Application in 2023
Figure 26. Global Cell-Based Immunotherapy Market Share by Application (2019-2024)
Figure 27. Global Cell-Based Immunotherapy Market Share by Application in 2023
Figure 28. Global Cell-Based Immunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-Based Immunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-Based Immunotherapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-Based Immunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-Based Immunotherapy Sales Market Share by Region in 2023
Figure 44. China Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 50. South America Cell-Based Immunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-Based Immunotherapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-Based Immunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-Based Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-Based Immunotherapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-Based Immunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-Based Immunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-Based Immunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-Based Immunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-Based Immunotherapy Market Share Forecast by Application (2025-2030)
